Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Finished Goods (2016 - 2025)

INVO Fertility has reported Finished Goods over the past 15 years, most recently at $138148.0 for Q3 2025.

  • Quarterly Finished Goods fell 26.52% to $138148.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $138148.0 through Sep 2025, down 26.52% year-over-year, with the annual reading at $166227.0 for FY2024, 21.23% down from the prior year.
  • Finished Goods was $138148.0 for Q3 2025 at INVO Fertility, down from $161110.0 in the prior quarter.
  • Over five years, Finished Goods peaked at $222740.0 in Q3 2021 and troughed at $138148.0 in Q3 2025.
  • The 5-year median for Finished Goods is $196586.0 (2024), against an average of $195340.4.
  • Year-over-year, Finished Goods soared 104.57% in 2021 and then decreased 26.52% in 2025.
  • A 5-year view of Finished Goods shows it stood at $220168.0 in 2021, then decreased by 11.49% to $194879.0 in 2022, then grew by 8.29% to $211028.0 in 2023, then fell by 21.23% to $166227.0 in 2024, then dropped by 16.89% to $138148.0 in 2025.
  • Per Business Quant, the three most recent readings for IVF's Finished Goods are $138148.0 (Q3 2025), $161110.0 (Q2 2025), and $163798.0 (Q1 2025).